...
首页> 外文期刊>World Journal of Surgical Oncology >Comparison of thoracolaparoscopic esophagectomy with cervical anastomosis with McKeown esophagectomy for middle esophageal cancer
【24h】

Comparison of thoracolaparoscopic esophagectomy with cervical anastomosis with McKeown esophagectomy for middle esophageal cancer

机译:腹腔镜食管切除术与宫颈吻合术与McKeown食管切除术治疗中度食管癌的比较

获取原文
           

摘要

In China, the middle esophageal squamous cell cancer is the most common tumor type, and Mckeown esophagectomy (ME) is preferably adopted by thoracic surgeon. But, the surgical trauma of ME is great. Thoracolaparoscopic esophagectomy (TE) was developed to decrease the operative stress; however, the safety and efficacy were not defined. In this study, clinical outcomes were compared between patients who received ME and TE. The data of 113 patients who suffered from middle-thoracic esophageal cancer during the same period were collected. Sixty-two patients received ME (ME group), and 51 patients received TE (TE group). Patients’ demographics and short-term clinicopathologic outcomes were comparable between the two groups. Survival rate was estimated using the Kaplan–Meier method, and comparisons between groups were performed with log–rank test. Patients in TE group had lower body mass index (BMI). Preoperative tumor stage in TE group was much earlier. Both overall and thoracic operation time were longer in TE group. The blood loss during operation and postoperative day (POD) 1 was less in TE group, which contributed to the less blood transfusion. In TE group, postoperative incidence of pulmonary complications and atrial fibrillation (p?=?0.035 and p?=?0.033) was lower; the inflammatory response and incision pain were significantly alleviated; the ICU and in-hospital stay was shorter as well because of less surgical trauma. No statistically significant difference was found between two groups in terms of overall survival or disease-free survival. The efficacy and safety of TE were supported by the selected patients in this cohort study. Although it is lack of randomness in this research, some advantages of TE were gratifying such as lower postoperative complications and similar survival with ME. A multicenter prospective randomized study is now required.
机译:在中国,中段食道鳞状细胞癌是最常见的肿瘤类型,并且胸外科医师最好采用Mckeown食管切除术(ME)。但是,ME的手术创伤很大。开胸腹腔镜食管切除术(TE)是为了减少手术压力。但是,安全性和有效性尚未定义。在这项研究中,比较了接受ME和TE的患者的临床结局。收集同期113例中胸段食管癌患者的资料。 ME组62例,ME组51例。两组患者的人口统计学和短期临床病理结果相当。使用Kaplan-Meier方法评估存活率,并使用对数秩检验进行组间比较。 TE组患者的体重指数(BMI)较低。 TE组的术前肿瘤分期要早得多。 TE组的总体和胸腔手术时间均较长。 TE组术中和术后一日出血量(POD)1较少,这有助于减少输血。在TE组中,肺部并发症和心房纤颤的术后发生率较低(p≥0.035,p≥0.033)。炎症反应和切口疼痛明显减轻;由于较少的外科手术创伤,ICU和住院时间也缩短了。在总生存期或无病生存期方面,两组之间没有统计学上的显着差异。在这项队列研究中,所选患者支持了TE的疗效和安全性。尽管这项研究缺乏随机性,但TE的一些优势令人欣慰,例如术后并发症的发生率较低和ME的生存率相似。现在需要进行多中心前瞻性随机研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号